Clinical Trial Update: Comparing Immune Responses to Topical Imiquimod

View source ↗

Summary

A terminated clinical trial comparing immune responses to topical Imiquimod in actinic keratosis patients has ended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Imiquimod (imiquimod)

Snippet

Sponsor: University of California, Davis | Conditions: Actinic Keratoses | Status: TERMINATED